Qingping Tian

Title: Qingping Tian: Innovator in BTK Inhibitors

Introduction

Qingping Tian is a prominent inventor based in South San Francisco, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of Bruton's Tyrosine Kinase (BTK) inhibitors. With a total of 10 patents to his name, Tian's work has had a substantial impact on medical research and drug development.

Latest Patents

Among his latest patents, Tian has developed methods for preparing BTK inhibitors. One notable patent details the process for preparing the compound 2-{3'-hydroxymethyl-1-methyl-5-[5-((S)-2-methyl-4-oxetan-3-yl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-[3,4′]bipyridinyl-2′-yl}-7,7-dimethyl-3,4,7,8-tetrahydro-2H,6H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one. Additionally, he has provided methods for preparing tricyclic lactam compounds, further showcasing his innovative approach to pharmaceutical chemistry.

Career Highlights

Tian has worked with notable companies in the pharmaceutical industry, including Genentech, Inc. and Agouron Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Qingping Tian has collaborated with esteemed colleagues such as Srinivasan Babu and Zhigang Cheng. These partnerships have facilitated the exchange of ideas and fostered advancements in their shared field of expertise.

Conclusion

Qingping Tian's contributions to the development of BTK inhibitors and his extensive patent portfolio highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for innovative treatments and advancements in medical research.